Adapthealth Corp (AHCO)vsEdwards Lifesciences Corp (EW)
AHCO
Adapthealth Corp
$10.79
-3.83%
HEALTHCARE · Cap: $1.49B
EW
Edwards Lifesciences Corp
$85.76
+2.49%
HEALTHCARE · Cap: $49.36B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 92% more annual revenue ($6.30B vs $3.29B). EW leads profitability with a 17.4% profit margin vs -2.4%. EW earns a higher WallStSmart Score of 61/100 (C+).
AHCO
Hold45
out of 100
Grade: D+
EW
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+66.7%
Fair Value
$31.68
Current Price
$10.79
$20.89 discount
Margin of Safety
+68.2%
Fair Value
$249.70
Current Price
$85.76
$163.94 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Strong operational efficiency at 31.2%
Safe zone — low bankruptcy risk
16.7% revenue growth
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 0.7%
Elevated debt levels
ROE of -5.3% — below average capital efficiency
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : AHCO
The strongest argument for AHCO centers on Price/Book.
Bull Case : EW
The strongest argument for EW centers on Operating Margin, Altman Z-Score, Revenue Growth. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bear Case : AHCO
The primary concerns for AHCO are Market Cap, Operating Margin, Debt/Equity.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.3x leaves little room for execution misses.
Key Dynamics to Monitor
AHCO profiles as a turnaround stock while EW is a growth play — different risk/reward profiles.
AHCO carries more volatility with a beta of 1.45 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
EW generates stronger free cash flow (-21M), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 45/100), backed by strong 17.4% margins and 16.7% revenue growth. AHCO offers better value entry with a 66.7% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Adapthealth Corp
HEALTHCARE · MEDICAL DEVICES · USA
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
Visit Website →Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?